HR 5219 · 114th Congress 2015โ€“2017, ended

Safe Medications for Moms and Babies Act of 2016

Latest action · May 13, 2016 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 12, 2016
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Safe Medications for Moms and Babies Act of 2016

This bill requires the Department of Health and Human Services to establish the Task Force on Research Specific to Pregnant Women and Lactating Women to report on issues including: (1) the development of safe and effective therapies for such women, (2) ethical issues surrounding the inclusion of such women in clinical research, and (3) federal research activities regarding such women.

The Food and Drug Administration must report specified information including the number of new drugs approved based on research that included such women in clinical trials.

Cosponsors 11

Members who signed on, in the order they did. Signatures ran from May 12, 2016 to Nov 16, 2016; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-FLKathy CastorOriginalMay 12, 2016
R-PARyan A. CostelloJun 21, 2016
D-CAGrace F. NapolitanoJul 25, 2016
D-FLDebbie Wasserman SchultzSep 6, 2016
D-CALois CappsSep 6, 2016
D-CALucille Roybal-AllardSep 6, 2016
R-NYJohn KatkoSep 12, 2016
D-RIDavid N. CicillineSep 26, 2016
D-MEChellie PingreeSep 28, 2016
D-NYEliot L. EngelNov 14, 2016
D-TNJim CooperNov 16, 2016

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 12, 2016
Health Subcommittee
Referred May 13, 2016

Actions 3

Everything that happened, newest first.

  1. May 13, 2016Referred to the Subcommittee on Health.
  2. May 12, 2016Introduced in House
  3. May 12, 2016Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Pursuant to the power granted to Congress under Article I, Section 8, Clause 3 of the U.S. Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 162, no. 75, May 12, 2016, page H2342.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To provide for the establishment of the Task Force on Research Specific to Pregnant Women and Lactating Women, to require an annual report to Congress on approved new drug applications with information on pregnancy and lactation, and for other purposes.
Short Titles as Introduced
Safe Medications for Moms and Babies Act of 2016

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 12, 2016Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.